The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. In a week that saw magic mushrooms making the… Read More
Throughout 2022, Exscientia has progressed AI-driven capabilities for virtual biologics design, such as human antibodies, and is now establishing an automated biologics laboratory in Oxford to internally generate and profile novel antibodies. Context Current approaches to optimise antibodies, even those that use machine learning, still… Read More
Clinical stage oncology company Avacta Group has moved its Therapeutics division to a new headquarters at Scale Space in Imperial College’s White City Campus, London. DDW Multimedia Editor Megan Thomas attended the open day to learn more about the company’s intentions. In this video, she speaks to Neil… Read More
Clinical stage oncology company Avacta Group has moved its Therapeutics division to a new headquarters at Scale Space in Imperial College’s White City Campus, London. DDW Multimedia Editor Megan Thomas attended the open day to learn more about the company’s intentions. In this video, she speaks… Read More
TrakCel recently announced the launch of its latest platform. Paul Viggers, Chief Commercial Officer at TrakCel, explains how it fits into the drug discovery and development sector. The catalysts Ten years ago, cell and gene therapy (CGT) was really finding its feet as success… Read More
Verge Genomics, a clinical-stage, tech-enabled biotechnology company using artificial intelligence (AI) and human data to transform drug discovery, has announced today that the first subject has been dosed in a Phase I clinical trial of VRG50635 for amyotrophic lateral sclerosis (ALS). VRG50635 is a small molecule inhibitor… Read More
Complement Therapeutics’ lead asset CTx001, an AAV-based gene therapy for the treatment of geographic atrophy (GA), has been awarded an Innovation Passport by the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA). CTx001 was awarded the Innovation Passport based on three criteria: that the condition addressed is… Read More
Australia’s drug discovery industry shows promise and innovation, as well as business opportunities. DDW’s Megan Thomas takes a look at some of the reasons why we should be keeping an interested eye on the developments coming out of this country. The Sector Snapshot 2022: Expansion is continuous … Read More
Listen to this article on the DDW Podcast: ‘Can synthetic biology save us?’ and ‘synthetic biology can benefit us all’, are just some of the headlines this emerging scientific field has recently elicited. Lu Rahman speaks to Dr Emily Leproust, Founder and CEO of Twist Biopharma, about the potential… Read More
The latest episode of the DDW Highlights podcast is now available for download. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. Over the last seven days we’ve seen discoveries that could… Read More
The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. Over the last seven days we’ve seen discoveries… Read More
Collaborative Drug Discovery (CDD) is hosting a webinar in which CDD’s Eric Gifford speaks with two industry experts, Dr Josh Horan and Dr Michael Kappler about their experience working with data at biotech companies. The live webinar will take place on December 1, 2022 at 8AM (PT), 11AM… Read More
This is the latest episode of the free narrated DDW podcast, “The role of animals in the future of drug discovery”. It covers two articles written for Volume 22, Issue 4 – Fall 2021 of DDW, narrated by DDW Multimedia Editor Megan Thomas. They are called “How an… Read More
This is the latest episode of the free DDW podcast, “The role of animals in the future of drug discovery”. It covers two articles written for Volume 22, Issue 4 – Fall 2021 of DDW, narrated by DDW Multimedia Editor Megan Thomas. They are called “How an animal model… Read More
Sphere Fluidics, a company developing single cell analysis systems, has opened a new facility in Granta Park, Cambridgeshire, UK. Doubling overall capacity, the laboratories enable the team’s expansion and the development of new products. The new laboratories are in addition to offices at… Read More
Optibrium, a software and artificial intelligence (AI) solutions developer for drug discovery, has announced three appointments: Michelle Harrison as Head of Strategic Marketing, Chris Khoury as Associate Director of Business Development, and Imran Ghauri as Business Development Manager. The company says the appointments will bring extensive AI… Read More
